Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Employee and Director Benefits (Tables)

v3.23.1
Note 7 - Employee and Director Benefits (Tables)
3 Months Ended
Mar. 31, 2023
Notes Tables  
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
                   

Weighted

         
           

Weighted

   

Average

         
           

Average

   

Remaining

         
           

Exercise

   

Contractual

   

Aggregate

 
   

Shares

   

Price

   

Term (years)

   

Intrinsic Value

 
                           

(In Thousands)

 

Three Months Ended March 31, 2023:

                               

Outstanding January 1, 2023

    280,000     $ 19.43       3.0     $ 14,088  

Exercised

    (75,000 )     10.80       0.9       3,288  

Outstanding March 31, 2023

    205,000     $ 22.59       3.4     $ 7,428  
                                 

Exercisable March 31, 2023

    152,000     $ 17.28       2.2     $ 5,859  
                                 

Three Months Ended March 31, 2022:

                               

Outstanding January 1, 2022

    353,250     $ 19.28       3.8     $ 23,525  

Exercised

    (36,500 )     18.65       3.1       2,677  

Outstanding March 31, 2022

    316,750     $ 19.35       3.7     $ 24,446  
                                 

Exercisable March 31, 2022

    255,000     $ 14.79       2.8     $ 20,056  
Share-Based Payment Arrangement, Outstanding Award, Activity, Excluding Option [Table Text Block]
   

Restricted Stock

   

Performance Shares

 
   

Shares

   

Weighted Average Grant Date Fair Value

   

Shares

   

Weighted Average Grant Date Fair Value

 

Three Months Ended March 31, 2023:

                               

Non-vested at January 1, 2023

    141,580     $ 56.39       23,852     $ 54.16  

Granted

    27,258       69.83       8,091       70.29  

Vested

    (17,521 )     48.32       -       -  

Forfeited

    (6,545 )     69.90       -       -  

Non-vested at March 31, 2023

    144,772     $ 59.29       31,943     $ 58.25  
                                 

Three Months Ended March 31, 2022:

                               

Non-vested at January 1, 2022

    127,602     $ 42.27       12,437     $ 37.05  

Granted

    27,851       84.67       6,557       74.52  

Vested

    (9,612 )     42.23       -       -  

Forfeited

    (877 )     40.72       -       -  

Non-vested at March 31, 2022

    144,964     $ 50.43       18,994     $ 49.99